HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

eniluracil

structure in first source; inactivates dihydropyrimidine dehydrogenase
Also Known As:
5-ethynyluracil; 776C85; GW776C85; compound 776C; 2,4(1H,3H)-Pyrimidinedione, 5-ethynyl-
Networked: 56 relevant articles (9 outcomes, 37 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hohneker, J: 4 articles (04/2002 - 04/2000)
2. Levin, J: 4 articles (04/2002 - 04/2000)
3. Spector, T: 4 articles (11/2000 - 02/2000)
4. Rivera, Edgardo: 3 articles (02/2014 - 02/2002)
5. Levin, Jeremey: 3 articles (03/2002 - 01/2002)
6. Schilsky, R L: 3 articles (04/2001 - 04/2000)
7. Spector, Thomas: 2 articles (02/2014 - 01/2010)
8. Cohen, Darrel P: 2 articles (02/2006 - 03/2004)
9. Czito, Brian G: 2 articles (02/2006 - 03/2004)
10. Hong, Timothy J: 2 articles (02/2006 - 03/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Colorectal Neoplasms (Colorectal Cancer)
3. Breast Neoplasms (Breast Cancer)
4. Squamous Cell Carcinoma (Epidermoid Carcinoma)
5. Dihydropyrimidine Dehydrogenase Deficiency

Related Drugs and Biologics

1. Fluorouracil (Carac)
2. eniluracil
3. Leucovorin (Folinic Acid)
4. Capecitabine (Xeloda)
5. Cytotoxins (Cytolysins)
6. 2',3'- O- diacetyl- 5'- deoxy- 5- vinylcytidine
7. 5-vinyluracil
8. brivudine (brivudin)
9. Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)
10. Anthracyclines

Related Therapies and Procedures

1. Oral Administration
2. Radiotherapy
3. Drug Therapy (Chemotherapy)
4. Therapeutics